If I'm right, we are due a progress update in Q4 about Prima's...

If I'm right, we are due a progress update in Q4 about Prima's work on the oral Gardasil (HPV) vaccine delivery system.

Obviously there are other companies (AHZ for example) looking at HPV but with Prof Frazer also advising Prima, it makes one wonder if Prima are only looking at oral delivery or perhaps delivery plus drug variation to tackle other cancers. I believe it's the former but am not sure.

If we could see promise out of this oral Gardasil initiative alone, it would surely be cause for more inward investment.

I suspect that by about mid 2012 we should hopefully have seen some really good news flow from Prima. Not sure how markets will be looking at that time of course, but even with the sometimes large swings down as well as up, I am comfortable to hold until my target is reached. Selling now to try to re-enter at a lower price is to me a poor man's gamble. At least I would end up losing my money and becoming a poor man. Much better to be patient and get out based on an appreciated SP resulting from solid company progress.

That's definitely not advice to anyone. It's just what I feel will work for me personally.